Sort
25,944 grants matching “neurodegeneration”
Core D: Neuroimaging Core
$4,251,051Bradley T Christian · University Of Pittsburgh At Pittsburgh · U19 · FY2021 · AG
Age-related Tauopathy in HIV-associated Neurocognitive Disorders
$4,235,695Susan Morgello · Icahn School Of Medicine At Mount Sinai · RF1 · FY2018 · AG
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)
$4,203,503Robert H Mach · University Of Pennsylvania · U19 · FY2020 · NS
NAPS2 Administrative Core
$4,185,073Yo-El S Ju · Washington University · U19 · FY2025 · AG
NAPS2 Administrative Core
$4,174,867Yo-El S Ju · Washington University · U19 · FY2022 · AG
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias
$4,159,504Anne M Murray · Hennepin Healthcare Research Institute · RF1 · FY2022 · AG
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)
$4,155,123Robert H Mach · University Of Pennsylvania · U19 · FY2022 · NS
Stroke Disordered Breathing and its Impact on Cognitive Decline in Aging, Alzheimer's Disease and Cerebral Amyloid Angiopathy
$4,137,716Jun Li · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2020 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
$4,130,041Emily J Rogalski · Northwestern University At Chicago · U19 · FY2021 · AG
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4)
$4,116,300William S Kremen · University Of California, San Diego · R01 · FY2023 · AG
National Alliance for Medical Image Computing (NAMIC)
$4,113,847Ron Kikinis · Brigham And Women'S Hospital · U54 · FY2010 · EB
Integrated understanding of complex viral network biology in Alzheimer's Disease
$4,111,077Michelle E Ehrlich · Icahn School Of Medicine At Mount Sinai · RF1 · FY2019 · AG
Human Biochemical Genetics
$4,093,963William Gahl · National Human Genome Research Institute · ZIA · FY2012 · HG
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$4,083,505Elizabeth Head · University Of California-Irvine · RF1 · FY2022 · AG
Tau Pathology in CTE vs. Alzheimer's Disease: Microvasculopathy and Neuroinflammation
$4,071,754Ann Carolyn McKee · Boston University Medical Campus · RF1 · FY2017 · AG
Vanderbilt Memory & Aging Project
$4,068,747Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2020 · AG
PET Radiopharmaceutical Sciences
$4,051,138Victor W Pike · National Institute Of Mental Health · ZIA · FY2017 · MH
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$4,040,367John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Demystifying Microglia in Aging and Alzheimer's Disease
$4,028,422Li-Huei Tsai · Massachusetts Institute Of Technology · RF1 · FY2016 · AG
Attention and Semantic Evaluation as Predictors of Empathy in Healthy Aging and Frontotemporal Dementia
$4,022,337Katherine P Rankin · University Of California, San Francisco · RF1 · FY2019 · AG
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease
$4,020,661Reisa A. Sperling · Brigham And Women'S Hospital · R01 · FY2016 · AG
PET Radiopharmaceutical Sciences
$4,020,053Victor W Pike · National Institute Of Mental Health · ZIA · FY2016 · MH
PET Radiopharmaceutical Sciences
$4,011,506Victor W Pike · National Institute Of Mental Health · ZIA · FY2010 · MH
Human Biochemical Genetics
$4,008,647William Gahl · National Human Genome Research Institute · ZIA · FY2025 · HG
Microglial apoE in neuroinflammation and Alzheimer's disease
$4,000,570John David Fryer · Mayo Clinic Arizona · RF1 · FY2019 · AG